Literature DB >> 15333652

Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.

M T Kennedy1, R C K Jordan, K W Berean, B Perez-Ordoñez.   

Abstract

BACKGROUND: Intestinal-type sinonasal adenocarcinoma (ITAC) is an uncommon neoplasm, which resembles adenocarcinoma of the gastrointestinal tract. ITAC occurs sporadically or in association with occupational exposure to hardwood dust and other agents. AIMS: To investigate the phenotype and possible pathogenetic mechanisms of primary sinonasal and nasopharyngeal adenocarcinomas by staining for cytokeratin 7 (CK7), CK20, CDX-2, and villin.
METHODS: Twelve sporadic sinonasal and nasopharyngeal adenocarcinomas were stained with monoclonal antibodies to CK7, CK20, CDX-2, and villin. The ITACs were classified as papillary, colonic, solid, mixed, or mucinous types.
RESULTS: The diagnosis of ITAC was confirmed in 10 cases: five were colonic type and five were papillary. One was a sinonasal papillary low grade adenocarcinoma, and one a papillary nasopharyngeal adenocarcinoma, and these tumours were CK7 positive, but CK20, CDX-2, and villin negative. All ITACs were positive for CK20, CDX-2, and villin, and six were CK7 positive. One ITAC had a focus of intestinal metaplasia away from the invasive carcinoma.
CONCLUSIONS: Sinonasal ITACs have a distinctive phenotype, with all cases expressing CK20, CDX-2, and villin. Most ITACs also express CK7, although a proportion of tumours are CK7 negative. ITAC seems to be preceded by intestinal metaplasia of the respiratory mucosa, which is accompanied by a switch to an intestinal phenotype. Although ITACs are morphologically similar, differences in cytokeratin expression patterns suggest two distinct types. The expression pattern of CK7, CK20, CDX-2, and villin positive may be useful in separating these tumours from other non-ITAC adenocarcinomas of the sinonasal tract and nasopharynx.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15333652      PMCID: PMC1770431          DOI: 10.1136/jcp.2004.016964

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  30 in total

1.  CDX-2 homeobox gene expression.

Authors:  Alessandro Franchi; Daniela Massi; Gianna Baroni; Marco Santucci
Journal:  Am J Surg Pathol       Date:  2003-10       Impact factor: 6.394

2.  Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach.

Authors:  T Mizoshita; K Inada; T Tsukamoto; Y Kodera; Y Yamamura; T Hirai; T Kato; T Joh; M Itoh; M Tatematsu
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

3.  TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.

Authors:  Federica Perrone; Maria Oggionni; Sarah Birindelli; Simona Suardi; Silvia Tabano; Roberta Romano; Maria Luisa Moiraghi; Gabriella Bimbi; Pasquale Quattrone; Giulio Cantu; Marco A Pierotti; Lisa Licitra; Silvana Pilotti
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

4.  Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.

Authors:  P Chu; E Wu; L M Weiss
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

5.  CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.

Authors:  Robert W Werling; Hadi Yaziji; Carlos E Bacchi; Allen M Gown
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

6.  Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes.

Authors:  Marta Marchetti; Elise Caliot; Eric Pringault
Journal:  J Cell Sci       Date:  2003-04-15       Impact factor: 5.285

7.  Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract.

Authors:  A I Kende; N J Carr; L H Sobin
Journal:  Histopathology       Date:  2003-02       Impact factor: 5.087

8.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Authors:  Akashi Eda; Hiroyuki Osawa; Kiichi Satoh; Ichiro Yanaka; Ken Kihira; Yumiko Ishino; Hiroyuki Mutoh; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

9.  Sinonasal adenocarcinoma: immunohistochemical marking and expression of oncoproteins.

Authors:  Amani A Bashir; Robert A Robinson; Jo A Benda; Russell B Smith
Journal:  Head Neck       Date:  2003-09       Impact factor: 3.147

10.  Sinonasal tract seromucous adenocarcinomas: a report of 12 cases.

Authors:  A G Neto; K Pineda-Daboin; M A Luna
Journal:  Ann Diagn Pathol       Date:  2003-06       Impact factor: 2.090

View more
  24 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Colonic-type adenocarcinoma of the base of the tongue: a case report of a rare neoplasm.

Authors:  Denisa Slova; Alberto Paniz Mondolfi; Ioana Moisini; Gabriel Levi; Mark Urken; Jose Zevallos; Sharmeen Mansoor; Azita Khorsandi; Dov Bloch; Ramapriya Vidhun; Bruce Wenig
Journal:  Head Neck Pathol       Date:  2011-09-25

3.  Intestinal metaplasia of the sinonasal mucosa adjacent to intestinal-type adenocarcinoma. A morphologic, immunohistochemical, and molecular study.

Authors:  Alessandro Franchi; Annarita Palomba; Lucia Miligi; Valentina Ranucci; Duccio Rossi Degli Innocenti; Antonella Simoni; Monica Pepi; Marco Santucci
Journal:  Virchows Arch       Date:  2014-11-28       Impact factor: 4.064

4.  A Subset of Sinonasal Non-Intestinal Type Adenocarcinomas are Truly Seromucinous Adenocarcinomas: A Morphologic and Immunophenotypic Assessment and Description of a Novel Pitfall.

Authors:  Bibianna Purgina; Jassem M Bastaki; Umamaheswar Duvvuri; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2015-02-19

Review 5.  Primary Intestinal-Type Adenocarcinoma of Tongue: A Case Report with Immunohistochemical and Molecular Profiles and Review of the Literature.

Authors:  Siavash Rahimi; Iolia Akaev; Costa Repanos; Peter A Brennan; Jean Daniel Dubois
Journal:  Head Neck Pathol       Date:  2016-10-17

Review 6.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

7.  Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Authors:  Vera N Senchenko; Natalia P Kisseljova; Tatyana A Ivanova; Alexey A Dmitriev; George S Krasnov; Anna V Kudryavtseva; Grigory V Panasenko; Evgeny B Tsitrin; Michael I Lerman; Fyodor L Kisseljov; Vladimir I Kashuba; Eugene R Zabarovsky
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

8.  Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype.

Authors:  Diana Bell; Michael E Kupferman; Michelle D Williams; Asif Rashid; Adel K El-Naggar
Journal:  Hum Pathol       Date:  2009-08-19       Impact factor: 3.466

9.  Comparison of endoscopic and external resections for sinonasal instestinal-type adenocarcinoma.

Authors:  Geoffrey Mortuaire; Xavier Leroy; Claire Vandenhende-Szymanski; Dominique Chevalier; Anne-Sophie Thisse
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

10.  Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.

Authors:  Matthew P Tilson; Gary L Gallia; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2013-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.